Key result
Anticardiolipin antibodies in a patient with alcoholic cardiomyopathy were associated with deep vein thrombosis, peripheral arterial and pulmonary embolism, and death at age 44.
Case Report (n=1)
The presence of anticardiolipin antibodies in a patient with alcoholic cardiomyopathy was associated with severe thrombotic complications and death, suggesting a worse prognosis.
Answers are grounded in this paper and cite their sources.
May indicate poorer prognosis in alcoholic cardiomyopathy with anticardiolipin antibodies; hypothesis-generating for screening and antithrombotic trials.
Anticardiolipin antibodies are associated with arterial and venous thrombosis, and repetitive miscarriages. The involvement of the heart has been described frequently and can evolve into cardiomyopathy. It has been known for some decades that chronic alcoholism can lead to alcoholic cardiomyopathy (ACM). The objective of this study was to evaluate whether anticardiolipin antibodies represent a worse prognosis for patients with ACM. The authors present a case of a chronic alcoholic patient (30 y of alcoholism) who died at 44 y of age, and who was considered positive for anticardiolipin antibodies. The patient developed deep vein thrombosis, and peripheral arterial and pulmonary embolism. The presence of another risk factor seems to represent a worse prognosis for patients with ACM.
No takes yet. Share an insight, caveat, or question.
Godoy et al. (2008) conducted a case report in Alcoholic Cardiomyopathy (n=1). Anticardiolipin antibodies was evaluated on Prognosis (development of thrombosis, embolism, and death). Anticardiolipin antibodies in a patient with alcoholic cardiomyopathy were associated with deep vein thrombosis, peripheral arterial and pulmonary embolism, and death at age 44.
Synapse has enriched 10 related papers. Consider them for comparative context: